Autopsy report · NCT00223938

Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.

“The study was terminated because of significant enrollment challenges”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 8 months after it had already started.
• Ran for about 3 years 4 months before it stopped.
• 112 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Sanofi

Sponsor type

Industry

Conditions

Anemia

Interventions

Oral Iron; sodium ferric gluconate; sodium ferric gluconate

Participants

112

Sites

8

Countries

United States

Trials that died the same way

• Evaluation of the Consumption of a Probiotic on the Load of S. Agalactiae.
  “The study was terminated due to low enrollment” (93% match in meaning)
• Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel
  “The study is terminated due to lower enrollment” (93% match in meaning)
• Use of Teriparatide to Accelerate Fracture Healing
  “The study was terminated due to poor enrollment.” (93% match in meaning)
• Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
  “the study was terminated early due to poor enrollment” (92% match in meaning)
• BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations
  “Study was terminated due to low enrollment.” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.